Biotechnology News

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen: The only lab test to run four prenatal genetic screens simultaneously as early as eight weeks

U.S. Commercial launch of Gen 2 Monarch System commencing today, July 21, 2026Gen 2 Monarch device provides an enhanced patient experience while delivering clinically proven therapeutic stimulation of...

SAN FRANCISCO, July 21, 2026 (GLOBE NEWSWIRE) -- Revagenix, Inc., a biopharmaceutical company developing targeted, purpose-built medicines for serious chronic diseases, today announced the promotion...

Preliminary data reinforces IMNN-001 immunotherapy’s potential for success in the rapidly recruiting Phase 3 OVATION 3 clinical trial Lower rate of minimal residual disease (MRD)Higher ctDNA...

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...

RESEARCH TRIANGLE PARK, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics, Inc., a clinical-stage biotechnology company developing regenerative biologic medicines for chronic wounds,...

PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2026 financial results on Tuesday,...

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of VYNE’s...

GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people...

Lonza grants Engitix target-specific license for GlycoConnect®, HydraSpace® and SYNtecan E™ linker-payload technologies for ADC developmentCollaboration enables innovative treatments by combining...